(Q36874335)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17620046%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

review article

1 reference

title

Recent development in pharmacogenomics: from candidate genes to genome-wide association studies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17620046%20AND%20SRC:MED&resulttype=core&format=json

genome-wide association study

1 January 2020

main subject

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17620046%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

2

Hakon Hakonarson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17620046%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

1 July 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17620046%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17620046%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17620046%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

371-393

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17620046%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17620046%20AND%20SRC:MED&resulttype=core&format=json

Pharmacogenetics: the Dx perspective

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Pharmacogenetics place in modern medical science and practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Pharmacogenetics and the practice of medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Sequencing drug response with HapMap

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

How molecular profiling could revolutionize drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Measuring the value of pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Drug metabolism and variability among patients in drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Cytochrome P450 2C8: substrates, inhibitors, pharmacogenetics, and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Readmissions and adverse drug reactions in internal medicine: the economic impact.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Heterogeneity of therapeutic responses in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Molecular basis of ethnic differences in drug disposition and response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Positional cloning of a quantitative trait locus on chromosome 13q14 that influences immunoglobulin E levels and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Characterization of a common susceptibility locus for asthma-related traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Pharmacogenetics: more than skin deep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Pharmacogenetics of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Pharmacogenetics, pharmacogenomics and airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Pharmacogenetics and future drug development and delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Current concepts on the genetics of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Significant variability in response to inhaled corticosteroids for persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Osteoporosis in the corticosteroid-treated patient with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Selection of controls in database case-control studies: glucocorticoids and the risk of glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Use of inhaled corticosteroids and the risk of cataracts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

General principles for systematic reviews and meta-analyses and a critique of a recent systematic review of long-acting beta-agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Beta 2-adrenergic receptor polymorphisms and haplotypes are associated with airways hyperresponsiveness among nonsmoking men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Using single nucleotide polymorphisms as a means to understanding the pathophysiology of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Single nucleotide polymorphisms as tools in human genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Single nucleotide polymorphisms and the future of genetic epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Association between bronchodilating response to short-acting beta-agonist and non-synonymous single-nucleotide polymorphisms of beta-adrenoceptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Beta(2)-adrenergic receptor polymorphisms and response to salbutamol among Indian asthmatics*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Benefit-risk assessment of long-acting beta2-agonists in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Influence of beta2-adrenergic receptor genotype on airway function during exercise in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Pharmacogenetics in drug regulation: promise, potential and pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

The genetics of human drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Genetic Determinants of 5–Lipoxygenase Transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Variant LTC(4) synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Leukotriene C4 synthase polymorphisms and responsiveness to leukotriene antagonists in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Efficacy of inhaled corticosteroids in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

The effects of hydrocortisone on in vitro lymphocyte proliferation and interleukin-2 and -4 production in corticosteroid sensitive and resistant subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Mechanisms of corticosteroid resistance in asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Profiling of genes expressed in peripheral blood mononuclear cells predicts glucocorticoid sensitivity in asthma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Effect of interleukin-1beta and tumor necrosis factor-alpha on the expression of G-proteins in CD4+ T-cells of atopic asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Transcription factors in asthma: are transcription factors a new target for asthma therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

From willow bark to peptides: the ever widening spectrum of NF-kappaB inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Functional variants of OCTN cation transporter genes are associated with Crohn disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

A genome-wide association study identifies IL23R as an inflammatory bowel disease gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Interleukin-23 drives innate and T cell-mediated intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

21 January 2018

Replication publication

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Inhibition of allergen-induced airway obstruction and leukotriene generation in atopic asthmatic subjects by the leukotriene biosynthesis inhibitor BAYx 1005

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Future of biomarkers in acute coronary syndromes: moving toward a multimarker strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Deconstructing the relationship between genetics and race

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Genetic variation, classification and 'race'

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Changing the paradigm from 'race' to human genome variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Pharmacogenetics in heart failure: genomic markers of endothelial and neurohumoral function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Single nucleotide polymorphisms predict the change in left ventricular mass in response to antihypertensive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Tumor necrosis factor alpha polymorphism in heart failure/cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Pharmacogenomics of blood pressure response to antihypertensive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Global and societal implications of the diabetes epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Allosteric activators of glucokinase: potential role in diabetes therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Linkage of type 2 diabetes to the glucokinase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Neonatal diabetes mellitus due to complete glucokinase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Hyperexcitability to sulphonylurea in MODY3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

No deterioration in glycemic control in HNF-1alpha maturity-onset diabetes of the young following transfer from long-term insulin to sulphonylureas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

High-dose glibenclamide can replace insulin therapy despite transitory diarrhea in early-onset diabetes caused by a novel R201L Kir6.2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

The identification of a R201H mutation in KCNJ11, which encodes Kir6.2, and successful transfer to sustained-release sulphonylurea therapy in a subject with neonatal diabetes: evidence for heterogeneity of beta cell function among carriers of the R2

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

A genome-wide association study identifies novel risk loci for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the Indian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

A fat attack occurred in fat city

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

An insulin-degrading enzyme inhibitor decreases amylin degradation, increases amylin-induced cytotoxicity, and increases amyloid formation in insulinoma cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Apolipoprotein E, synaptic plasticity and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

APOE genotyping and response to drug treatment in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Prediction of successful weight reduction under sibutramine therapy through genotyping of the G-protein beta3 subunit gene (GNB3) C825T polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Modern science versus the stigma of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

The aetiology of obesity in children. A study of 101 twin pairs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Perspectives: molecular genetic research in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

The genetics of human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

A common genetic variant is associated with adult and childhood obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Comment on "A common genetic variant is associated with adult and childhood obesity"

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Involutional osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Perspective. How many women have osteoporosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Hip fractures in the elderly: a world-wide projection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Establishment of peak bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Segregation analysis and variance components analysis of bone mineral density in healthy families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Family history of osteoporosis and bone mineral density at the axial skeleton: the Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Prediction of bone density from vitamin D receptor alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Vitamin D receptor genotypes and bone mineral density.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Genetics of menopause-associated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Genetics of osteoporosis: role of steroid hormone receptor gene polymorphisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

COLIA1 Sp1 polymorphism predicts response of femoral neck bone density to cyclical etidronate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

High bone density due to a mutation in LDL-receptor-related protein 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Linkage of a gene causing high bone mass to human chromosome 11 (11q12-13)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Human thiopurine S-methyltransferase pharmacogenetics: variant allozyme misfolding and aggresome formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Methylenetetrahydrofolate reductase gene polymorphisms and response to fluorouracil-based treatment in advanced colorectal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Imatinib mesylate--a new oral targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Smart drugs: tyrosine kinase inhibitors in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Pharmacogenetics and drug therapy in psychiatry--the role of the CYP2D6 polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

The pharmacogenetics research network: from SNP discovery to clinical drug response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Clinical pharmacogenetics of immunosuppressive drugs in organ transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Role of CYP2C9 and its variants (CYP2C9*3 and CYP2C9*13) in the metabolism of lornoxicam in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

The relationship between the pharmacology of antiepileptic drugs and human gene variation: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Pharmacogenetics as a tool in the therapy of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

A mutation in the drug transporter gene ABCC2 associated with impaired methotrexate elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Epistasis: too often neglected in complex trait studies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Genome-wide strategies for detecting multiple loci that influence complex diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Epistasis and the genetics of human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

The Ubiquitous Nature of Epistasis in Determining Susceptibility to Common Human Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Shaking the tree: mapping complex disease genes with linkage disequilibrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Association study designs for complex diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Genetic associations: false or true?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Finding genes that underlie complex traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

"Are we there yet?": Deciding when one has demonstrated specific genetic causation in complex diseases and quantitative traits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Genetic association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Genome-wide association studies for common diseases and complex traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Genome-wide association studies: theoretical and practical concerns

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Toward genome-wide SNP genotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Complement factor H polymorphism in age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Association of variants of transcription factor 7-like 2 (TCF7L2) with susceptibility to type 2 diabetes in the Dutch Breda cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Association between β2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Association of Organic Cation Transporter Risk Haplotype With Perianal Penetrating Crohn’s Disease but Not With Susceptibility to IBD

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Association Analysis of 6,736 U.K. Subjects Provides Replication and ConfirmsTCF7L2as a Type 2 Diabetes Susceptibility Gene With a Substantial Effect on Individual Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Association of Transcription Factor 7-Like 2 (TCF7L2) Variants With Type 2 Diabetes in a Finnish Sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Variant of Transcription Factor 7-Like 2 (TCF7L2) Gene and the Risk of Type 2 Diabetes in Large Cohorts of U.S. Women and Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Transcription Factor TCF7L2 Genetic Study in the French Population: Expression in Human -Cells and Adipose Tissue and Strong Association With Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Comment on "A Common Genetic Variant Is Associated with Adult and Childhood Obesity"

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Family-based association analysis of β2-adrenergic receptor polymorphisms in the childhood asthma management program

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

What makes a good genetic association study?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.4.371

Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC)

21 January 2018

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1183/09031936.98.12020315

Identifiers

DOI

10.1586/14737159.7.4.371

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17620046%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference